Imperagen Raises £5M Seed

Imperagen raised £5M in a Seed round announced on May 21, 2026. ultra-fast enzyme engineering platform.

Round size
£5M
Stage
Seed
Headquarters
United Kingdom
Announced
May 21, 2026

The company

ultra-fast enzyme engineering platform.

The funding

Imperagen, based in Manchester, United Kingdom, announced £5M in Seed financing on May 21, 2026.

Participants include Northern Gritstone, IQ Capital, PXN Ventures.

Where the funding goes

    Sources

    1. Tech.eu Funding Explorer
    03 / Related rounds

    Related funding rounds

    01
    Series B · Healthtech

    Isomorphic Labs

    UK-based AI-first drug design and development company.

    Led by Thrive Capital
    $2.1B
    02
    Growth · Healthtech

    Uromems

    UroMems is a medical device company developing smart active implantable technology to treat stress urinary incontinence in women and men.

    $60M
    03
    Series B · Healthtech

    NVision Imaging

    Developer of MRI polarizers and hyperpolarized imaging agents.

    $55M